Influence of ACTH on activity of some granulocytic proteases in patients with multiple sclerosis
Czernicki, J.; Tchórzewski, H.; Chmielewski, H.
Archivum Immunologiae et Therapiae Experimentalis 27(3): 345-349
1979
ISSN/ISBN: 0004-069X PMID: 224833 Document Number: 149805
The effect of treatment with ACTH on activity of granulocytic acid and neutral proteases in patients suffering from multiple sclerosis was studied. Protease activity was distinctly higher in granulocytes from patients. ACTH normalized the activities investigated in patients with exacerbating course multiple sclerosis, but had no influence on hydrolases in the progressive form of the disease.
Document emailed within 1 workday
Related Documents
Wender, M.; Michałowska, G. 1986: IgG synthesis in the cerebrospinal fluid in patients with the chronic progressive phase of multiple sclerosis treated with cyclophosphamide and ACTH Neurologia i Neurochirurgia Polska 20(6): 536-541Carter, J.L.; Hafler, D.A.; Dawson, D.M.; Orav, J.; Weiner, H.L. 1988: Immunosuppression with high-dose I.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients Neurology 38(7 Suppl 2: 9-14
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Wender, M.; Tokarz-Kupczyk, E.; Mularek, O. 1988: Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH Neurologia i Neurochirurgia Polska 22(5): 399-403
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Zagórski, T.; Dudek, I.; Berkan, L.; Mazurek, M.; Kedziora, J.; Chmielewski, H. 1991: Superoxide dismutase (SOD-1) activity in erythrocytes of patients with multiple sclerosis Neurologia i Neurochirurgia Polska 25(6): 725-730
Pál, E.; Varjú, G.; Vécsei, L.; Szekeres, J.; Pálffy, G. 1997: Natural killer cell activity in multiple sclerosis patients Orvosi Hetilap 138(50): 3167-3170
Adamczyk-Sowa, M.; Pierzchala, K.; Sowa, P.; Polaniak, R.; Kukla, M.; Hartel, M. 2014: Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 65(4): 543-550
Merrill, J.E.; Wåhlin, B.; Sidén, A.; Perlmann, P. 1982: Elevated direct and IgM enhanced ADCC activity in multiple sclerosis patients Journal of Immunology 128(4): 1728-1735
Knight, S.C.; Abbosh, J.; Lance, E.M. 1976: The effect of intensive immunosuppression on the in vitro activity of lymphocytes from multiple sclerosis patients Postgraduate Medical Journal 52(5 Suppl): 131-135
De Medio, G.E.; Amaducci, L.; Borri, P.; Gaiti, A.; Porcellati, G. 1972: Lecithin: cholesterol acyl-transferase activity in the plasma of patients with multiple sclerosis Acta Neurologica 27(2): 101-107
Belenko, E.A.; Vorob'eva, O.V. 2012: Characteristics of the autonomous control of cardiac activity in patients with remitting multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(3 Part 1): 68-71
Braakman, E.; van Tunen, A.; Meager, A.; Lucas, C.J. 1986: Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit Clinical and Experimental Immunology 66(2): 285-294
Demakova, E.V.; Korobov, V.P.; Lemkina, L.M. 2003: Determination of gamma-aminobutyric acid concentration and activity of glutamate decarboxylase in blood serum of patients with multiple sclerosis Klinicheskaia Laboratornaia Diagnostika 4: 15-17
Tabira, T.; Webster, H.F.; Wray, S.H. 1975: Demyelinating activity of cerebrospinal fluid from multiple sclerosis patients tested in a new model system, the optic nerves of xenopus tadpoles Transactions of the American Neurological Association 100: 103-106
Morante, Y.; Yarlequé, A. 1980: Proteases of snake venoms. Influence of chemical agents on the proteolytic activity of Lachesis muta Shushupe venom Acta Cientifica Venezolana 31(2): 148-153
Germaniuk, I.L.; Goĭdash, M.M. 1976: Aminoacyl-tRNA formation in the liver and skeletal muscles of rabbits under the influence of multiple injections of ACTH alone and in combination with sodium ribonucleinate Problemy Endokrinologii 22(2): 83-86
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Bernard, C.C. 1989: Influence of genetic factors on cell-mediated and humoral immunity in multiple sclerosis Israel Journal of Medical Sciences 25(12): 682-685